The Loop Has Closed: The Artificial Pancreas Program Comes to Life in Israel

Diabetes technology has vastly improved in the last decade, and most people with diabetes who have the opportunity to wear an insulin pump or a continuous glucose monitor are grateful for the assistance they provide. But even with these advanced tools, the biggest burdens of diabetes – the insulin dosing and blood sugar testing – still lie on the person with diabetes or a caregiver. Read more

New Recommendations For Artificial Pancreas Development

A panel of experts convened by the FDA and NIH to try to advance research and development of the artificial pancreas put forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.
The experts are in agreement that even with the advanced treatments available today… Read more

Wireless CGM Sensor – A Milestone on the Way to an Artificial Pancreas

Researchers from the University of California San Diego and GlySens Inc. have developed an implantable sensor that measures blood sugar continuously and transmits the information without wires, according to a Reuters report .
The device worked in one pig for more than a year and in another for nearly 10 months with no trouble, and the researchers hope to start a human study within a few months… Read more

Artificial Pancreas Shows Promise in Israel

An artificial pancreas recently developed at the National Center for Childhood Diabetes at Schneider Children’s Hospital in Israel, was tested on seven patients between the ages of 19 and 30. The device consists of a pump that releases insulin and a sensor, which is connected to a small computer which calculates the required amount of insulin to be delivered… Read more

Islet Sheet Technology

The Islet Sheet looks like a clear business card and feels wet and slick on the finger. You can see the islets, which look to the naked eye like fine white sand… Read more

Successful First Trial for Artificial Pancreas

The new artificial pancreas system developed at Boston University was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of type 1 diabetic patients in the first clinical trial conducted at Massachusetts General Hospital…. Read more

Subscribe to our Newsletter

Hide me